← Back to Search

Culturally Tailored App for Cannabis Use Disorder

N/A

Recruiting

Research Sponsored by University of Houston

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up week 1-6

Awards & highlights

Study Summary

This trial aims to develop a culturally adapted mobile app to help Black cannabis users with CUD. The app will be tested and data collected for analysis.

Who is the study for?

This trial is for Black adults with cannabis use disorder who want to manage anxiety or stress through cannabis use. Participants must be at least 18, speak English fluently, and have a motivation to reduce their cannabis consumption. They should not be in any legal substance misuse treatment or other psychotherapy for CUD, anxiety, or depression.Check my eligibility

What is being tested?

The study tests a new mobile app called CT-MICART designed specifically for Black individuals with CUD. It compares the effectiveness of this culturally tailored app against a control group without the intervention. The aim is to develop and assess the app's impact on managing cannabis use.See study design

What are the potential side effects?

Since this trial involves using an app rather than medication, traditional side effects are not expected. However, participants may experience discomfort or emotional distress when addressing their cannabis use habits.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ week 1-6

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~week 1-6

This trial's timeline: 3 weeks for screening, Varies for treatment, and week 1-6 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Engagement with the CT-MICART app

Qualitative Interview

Safety Aid Scale

Trial Design

1Treatment groups

Experimental Treatment

Group I: CT-MICART AppExperimental Treatment2 Interventions

Participants in this arm will receive daily EMAs for 6 weeks.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Control

2011

Completed Phase 4

~15780

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of HoustonLead Sponsor

147 Previous Clinical Trials

47,432 Total Patients Enrolled

Louisiana State University Health Sciences Center in New OrleansOTHER

114 Previous Clinical Trials

44,151 Total Patients Enrolled

National Institute on Minority Health and Health Disparities (NIMHD)NIH

382 Previous Clinical Trials

1,216,111 Total Patients Enrolled

Media Library

CT-MICART App Clinical Trial Eligibility Overview. Trial Name: NCT05566730 — N/A

Cannabis Use Research Study Groups: CT-MICART App

Cannabis Use Clinical Trial 2023: CT-MICART App Highlights & Side Effects. Trial Name: NCT05566730 — N/A

CT-MICART App 2023 Treatment Timeline for Medical Study. Trial Name: NCT05566730 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is it currently possible to join this research program?

"As indicated on clinicaltrials.gov, this research endeavour is actively looking for participants. It was first brought to public attention on June 14th 2023 and has been edited as recently as June 26th of the same year."

Answered by AI

What is the current quota for enrollment in this medical research study?

"Affirmative. The information hosted on clinicaltrials.gov verifies that this medical investigation is presently recruiting patients. This trial was first posted on June 14th 2023 and has had its details updated recently, being edited as of the 26th of June 2023. It aims to recruit 50 applicants from a single clinic site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Culturally Tailored Cannabis Use Disorder App

Lorra Garey 2023. "Culturally Tailored Cannabis Use Disorder App". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05566730.